Target intelligence / Profile preview

RNA, U6 small nuclear 880, pseudogene (RNU6-880P)

Target
RNU6-880P
Molecular classification
Pseudogene, Small nuclear RNA pseudogene (snRNA pseudogene)
01

Overview

RNU6-880P is a pseudogene related to the U6 small nuclear RNA family, which are normally critical for spliceosome function and pre-mRNA splicing in eukaryotic cells[1][3][6]. However, as a pseudogene, RNU6-880P does not produce functional RNA or snRNP complexes and is presumed to be non-expressed and non-functional within the genome[5]. The U6 snRNA family itself is one of the most highly conserved components of the spliceosome, but only a subset of annotated U6 loci in the human genome are transcribed and active; most are unexpressed pseudogenes like RNU6-880P[4][6]. These pseudogenes are considered genomic "backups" or remnants and do not play a known role in cell biology or pathophysiology[5][6]. Key distinctions: - RNU6-880P is not a receptor, enzyme, transporter, or any kind of therapeutic target. - This gene should be classified as a non-target, and its annotation is correct as a pseudogene, not a misnomer[5].

Other names
RNU6-880PRNA, U6 small nuclear 880, pseudogeneHGNC:47843NCBI Gene:106479955Ensembl:ENSG00000207256
02

Mechanism of action

None. There are no mechanisms of action associated with this pseudogene.

03

Biological functions

None known. Pseudogenes are generally non-functional remnants of gene duplication or retrotransposition events and do not contribute to known biological processes.
04

Disease associations

None established. As a pseudogene, RNU6-880P has no verified role in disease.
05

Safety considerations

None. Pseudogenes do not raise direct safety concerns or therapeutic challenges.
06

Interacting drugs

None. There are no drugs known to interact with this pseudogene, nor is it considered a drug target.
07

Biomarkers

None. RNU6-880P is not known as a biomarker for disease or treatment monitoring.

Beyond the preview

Go deeper on RNA, U6 small nuclear 880, pseudogene (RNU6-880P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 880, pseudogene (RNU6-880P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call